Knowledge Distillery

The outbreak of the novel disease COVID-19 caused by the SARS-CoV-2 virus has rapidly spread around the world. Increasing evidence has suggested that…

The aim of this case-control study was to determine which characteristics and outcomes of stroke are associated with COVID-19. The study included…

In this paper, the authors evaluated incidence and clinical features of Guillain-Barre syndrome (GBS) in a cohort of patients from two regions of…

Since the COVID-19 pandemic, caused by SARS-CoV-2, a growing body of evidence indicates that, besides common COVID-19 symptoms, patients may develop…

The aim of the study was to assess the risk of hospitalisation for COVID‐19 and death in a cohort of patients with Parkinson’s disease or Parkinsonism…

In this review, the authors discuss the evidence on occurrence of de novo seizures in patients with COVID-19, the consequences of this catastrophic…

The aim of this multicentre, European, cohort study involving 34 stroke centres in France, Italy, Spain, and Belgium, was to study early outcomes…

The severe form of COVID-19 tends to be associated with neurological deficits.

The CoronaVirus Disease 19 (COVID-19) pandemic is a threat of particular concern for people affected by chronic immune-mediated diseases, such as…

Multiple risk factors for mortality have been identified in patients with COVID-19.

Neurological manifestations are common in patients with COVID-19, but little is known about pathophysiological mechanisms. In this single-centre…

Narcolepsy type 1 (NT1) is a chronic rare hypersomnia of central origin requiring a combination of behavioural and pharmacological treatments. During…